Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$4.73B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$739M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$716M |
| 4 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$255M |
| 5 |
iShares MSCI ACWI ETF
ACWI
|
+$201M |
Top Sells
| 1 |
Apple
AAPL
|
+$782M |
| 2 |
Microsoft
MSFT
|
+$705M |
| 3 |
iShares MBS ETF
MBB
|
+$605M |
| 4 |
Linde
LIN
|
+$454M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$418M |
Sector Composition
| 1 | Technology | 17.22% |
| 2 | Healthcare | 10.49% |
| 3 | Financials | 9.69% |
| 4 | Communication Services | 7.9% |
| 5 | Consumer Discretionary | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ORC
2926
Orchid Island Capital
ORC
$1.03B
| $63K | ﹤0.01% |
4,290
-8,620
| -67% | -$127K |
|
2927
Southern Missouri Bancorp
SMBC
$639M
| $63K | ﹤0.01% |
2,587
-5,317
| -67% | -$129K |
|
2928
Vanguard Real Estate ETF
VNQ
$35B
| $63K | ﹤0.01% |
903
| – | – |
|
|
AVID
2929
DELISTED
Avid Technology Inc
AVID
| $63K | ﹤0.01% |
9,379
-18,971
| -67% | -$127K |
|
|
BIOC
2930
DELISTED
Biocept, Inc.
BIOC
| $63K | ﹤0.01% |
+788
| New | +$63K |
|
2931
Home Bancorp
HBCP
$437M
| $62K | ﹤0.01% |
2,546
-5,230
| -67% | -$127K |
|
2932
HF Foods Group
HFFG
$171M
| $62K | ﹤0.01% |
7,306
-215
| -3% | -$1.83K |
|
2933
MetroCity Bankshares
MCBS
$742M
| $62K | ﹤0.01% |
5,281
-10,853
| -67% | -$127K |
|
2934
Ryerson Holding
RYI
$707M
| $62K | ﹤0.01% |
11,504
-10,068
| -47% | -$54.3K |
|
|
SCTL
2935
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $62K | ﹤0.01% |
7,446
-18,953
| -72% | -$158K |
|
2936
ADT
ADT
$7.05B
| $61K | ﹤0.01% |
14,166
-10,943
| -44% | -$47.1K |
|
2937
Transcat
TRNS
$705M
| $61K | ﹤0.01% |
2,307
-4,603
| -67% | -$122K |
|
|
MCBC
2938
DELISTED
Macatawa Bank Corp
MCBC
| $61K | ﹤0.01% |
8,634
-17,867
| -67% | -$126K |
|
2939
AMES National
ATLO
$180M
| $60K | ﹤0.01% |
2,937
-6,106
| -68% | -$125K |
|
2940
Entravision Communication
EVC
$215M
| $60K | ﹤0.01% |
29,277
-40,613
| -58% | -$83.2K |
|
2941
Red River Bancshares
RRBI
$431M
| $60K | ﹤0.01% |
1,633
-3,359
| -67% | -$123K |
|
2942
VEON
VEON
$3.56B
| $60K | ﹤0.01% |
1,600
| – | – |
|
|
KDNY
2943
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $60K | ﹤0.01% |
4,371
-8,829
| -67% | -$121K |
|
|
ARD
2944
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
| $60K | ﹤0.01% |
5,081
-1,989
| -28% | -$23.5K |
|
2945
Akero Therapeutics
AKRO
$3.59B
| $59K | ﹤0.01% |
2,782
-2,236
| -45% | -$47.4K |
|
2946
Domo
DOMO
$643M
| $59K | ﹤0.01% |
5,940
-11,571
| -66% | -$115K |
|
2947
Investors Title Co
ITIC
$467M
| $59K | ﹤0.01% |
464
-943
| -67% | -$120K |
|
2948
VYNE Therapeutics
VYNE
$8.04M
| $59K | ﹤0.01% |
302
+83
| +38% | +$16.2K |
|
|
GTYH
2949
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
| $59K | ﹤0.01% |
13,161
-27,220
| -67% | -$122K |
|
|
ORBC
2950
DELISTED
ORBCOMM, Inc.
ORBC
| $59K | ﹤0.01% |
24,303
-48,967
| -67% | -$119K |
|